Cargando…
Analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy()
PURPOSE: To compare the outcomes of patients with intermediate risk prostate cancer (IR-PCa) treated with low-dose rate I-125 seed brachytherapy (LDR-BT) and targeted dose painting of a histologic dominant intra-epithelial lesion (DIL) to those without a DIL. METHODS: 455 patients with IR-PCa were t...
Autores principales: | Martell, Kevin, Roy, Soumyajit, Meyer, Tyler, Stosky, Jordan, Jiang, Will, Thind, Kundan, Roumeliotis, Michael, Bosch, John, Angyalfi, Steve, Quon, Harvey, Husain, Siraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286970/ https://www.ncbi.nlm.nih.gov/pubmed/32548323 http://dx.doi.org/10.1016/j.heliyon.2020.e04092 |
Ejemplares similares
-
Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma
por: Khanolkar, Rutvij A., et al.
Publicado: (2021) -
Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
por: Martell, Kevin, et al.
Publicado: (2017) -
Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer
por: Samson, Nina, et al.
Publicado: (2021) -
Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19
por: Martell, Kevin, et al.
Publicado: (2020) -
MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)